Skip to main content
Finemedix Co., Ltd. logo

Finemedix Co., Ltd. — Investor Relations & Filings

Ticker · 387570 ISIN · KR7387570005 KO Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 387570

About Finemedix Co., Ltd.

https://finemedix.com/en/

Finemedix Co., Ltd. is a medical device company that develops and manufactures surgical equipment, specializing in instruments for endoscopic procedures. The company's product portfolio supports diagnostic and therapeutic applications, including Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) and Fine Needle Biopsy (EUS-FNB) devices, hemostatic clips for bleeding control, and tools for Endoscopic Submucosal Dissection (ESD) and polypectomy. Finemedix operates on a prosumer model, directly involving medical personnel in the product development process to create devices tailored to clinical needs.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled “분기보고서” (Korean for Quarterly Report) and covers the period January 1, 2026 to March 31, 2026. It includes detailed financial and operational data (sales by product, production volumes, raw material costs, production facilities, etc.) rather than just announcing or linking to a report. It is therefore a full interim/quarterly report, matching the definition for category IR. Q1 2026
2026-05-14 Korean
단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings Classification · 85% confidence The document is a voluntary disclosure of a single sale and supply contract (단일판매·공급계약체결) by the company, detailing contract terms, counterparty, amounts, and period. It is not an annual or interim financial report, earnings release, management change, or financing update, but rather a routine regulatory announcement of a contract award. Such miscellaneous filings fall under the general Regulatory Filings category.
2026-04-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is titled "정기주주총회결과" (Annual General Meeting Results) and provides detailed voting outcomes for each agenda item, including approval of financial statements, amendments to the articles, officer appointments, and voting percentages. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (Code: DVA). There is no indication of a presentation or the full annual report, but rather the official meeting results.
2026-03-25 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for FineMedics Co., Ltd. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. It covers the fiscal year ending December 31, 2025. Since this is a full audit report containing the financial statements and auditor's opinion, it is classified as an Audit Report (AR). FY 2025
2026-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company '파인메딕스'. It provides a summary of the audit opinion (적정/Unqualified), key financial data (assets, liabilities, equity, profit/loss), and details regarding the auditor (동현회계법인). While it contains financial data, it is a standard regulatory disclosure announcement in Korea (DART system format) notifying the public that the audit report has been submitted, rather than the full, multi-page audit report document itself. Therefore, it is classified as a Report Publication Announcement. FY 2025
2026-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for FineMedix. It contains the agenda for the upcoming Annual General Meeting (AGM), including items such as the approval of financial statements, appointment of auditors, and director remuneration. While it contains financial data, it is primarily a proxy statement/notice document sent to shareholders to solicit votes and inform them of the meeting details, which falls under the 'Proxy Solicitation & Information Statement' category.
2026-03-10 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.